ClinicalTrials.gg
CompletedNCT05471726Updated Nov 9, 2026Results posted

Improving Post-discharge Antimicrobial Use

An interventional study of Prospective audit-and-feedback in Infections, sponsored by Iowa City Veterans Affairs Medical Center. Completed at 5 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Iowa City Veterans Affairs Medical Center · Not applicable, Interventional, and Health services research

How we know

Updated Nov 9, 2026Results postedStart date moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
21,842
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

One in five hospitalized patients is prescribed an antimicrobial at the time of discharge, and a large proportion of these post-discharge antimicrobials are unnecessary. The investigators will evaluate a novel method for reviewing post-discharge antimicrobial prescriptions in real-time with the goal of improving antimicrobial selection and duration.

Read the detailed description

Antimicrobial stewardship programs (ASPs) work to improve antibiotic prescribing within hospitals. ASPs often restrict their activities to inpatient antimicrobial-prescribing. However, at least 40% of all antimicrobial exposure associated with an acute-care hospital stay is prescribed at the time of hospital discharge (i.e., post-discharge). Post-discharge antimicrobials mediate clinical outcomes after discharge and may facilitate the spread of antimicrobial resistance.

Several studies have shown that post-discharge antimicrobial use is often inappropriate. For example, using national VA data, the investigators found that 61% of fluoroquinolone treatment days were prescribed at hospital discharge; manual chart reviews at 9 hospitals found that 40% of these post-discharge fluoroquinolone prescriptions were either unnecessary or sub-optimal. Other studies have found that 53-79% of all post-discharge antimicrobials are either unnecessary or sub-optimal.

Post-discharge antimicrobials are an important target for antimicrobial stewardship. However, inpatient stewardship metrics do not capture post-discharge antimicrobials and ASPs frequently do not evaluate these prescriptions. A 2016 VA survey found that less than 50% of hospitals routinely reviewed targeted antimicrobials at discharge. According to a 2016 survey in Michigan, only 17% of 48 hospitals had a process for reviewing outpatient antimicrobial orders at discharge.

It is unclear how inpatient stewardship resources can be effectively leveraged to improve post-discharge antimicrobial use. If the goal is to improve post-discharge antimicrobial use, a potentially effective strategy may be an audit-and-feedback process focused solely on prescriptions for patients who will soon be discharged. In this trial, the investigators will evaluate the feasibility and effectiveness of such a process.

02

Conditions studied

  • Infections

Browse trials for

Keywords

  • antibiotic prescriptions
  • hospital discharge
  • antibiotic stewardship
03

In context

Infections

2,097 studies on the registry are indexed under Infections; 361 are open to participants now.

This study's enrollment of 21,842 is above the median of 113 across 1,305 interventional studies indexed under Infections.

Browse Infections studies →

Lead sponsor

Iowa City Veterans Affairs Medical Center is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

--The local stewardship team agrees to implement the discharge stewardship intervention on at least one inpatient service or ward.

Exclusion criteria

Exclusion Criteria:

--The hospital already has an audit-and-feedback process in place that focuses on antimicrobial prescribing at hospital discharge.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
21,842 participants (actual)

Study arms

  • Experimental
    Prospective audit-and-feedback at discharge

    When hospitals are in the intervention arm, they will perform the audit-and-feedback process focused on patients receiving antimicrobials who have an anticipated discharge.

    Behavioral: Prospective audit-and-feedback

  • No intervention
    Standard of care

    When hospitals are in the control arm, they will not perform a stewardship process that focuses on hospital discharge.

Interventions

  • BehavioralProspective audit-and-feedback

    The stewardship team will review patients who are on antibiotics, have an uncomplicated infection, and are eligible to continue antibiotics after discharge. Any recommendations from the stewardship team about optimizing antibiotic therapy will be presented to the primary prescriber in real-time with the goal of improving antibiotic selection and duration at hospital discharge.

06

What researchers measure

Primary outcomes

  1. Number of Patients With Post-discharge Antibiotic Exposure

    Post-discharge antibiotic exposure captures the number of hospitalized patient who were discharged with an antibiotic to take after discharge.

    Time frame: Antibiotics prescribed at the time of hospital discharge for the patient to take after discharge

  2. Length of Post-discharge Antibiotic Therapy

    Duration in days of the post-discharge antibiotics that were prescribed

    Time frame: Antibiotics prescribed at the point of hospital discharge

Secondary outcomes

  1. Inpatient Antibiotic Length of Therapy

    Inpatient antibiotic LOT will be calculated by measuring inpatient LOT across all patients exposed to inpatient antibiotics on the participating services during the study period.

    Time frame: Every two-week period through study completion (48 weeks total)

  2. Percentage of Participants With Hospital Readmission

    Hospital readmissions reflect the need for (re) admission to an acute-care bed at a participating facility for any indication within 30 days of the patient's discharge.

    Time frame: 30 days from discharge

07

Results

Posted Nov 9, 2026
Limitations and caveats
1. Some hospitals only performed the intervention for a few months, so there were limited opportunities to optimize the audit-and-feedback process. 2. Our primary outcome did not account for whether there were improvements in antibiotic selection. 3. We were unable to gather data on post-discharge antibiotics prescribed to patients transferred to skilled nursing facilities or discharged on OPAT. 4. Our findings are only generalizable to similar hospitals with similar stewardship programs.

Participant flow

Antibiotic stewardship teams at acute-care hospitals were eligible to participate if they had not already implemented a prospective audit-and-feedback process focused on hospital discharge. Teams were recruited through the Centers for Disease Control and Prevention (CDC) EpiCenter's national conference calls and known professional contacts of the lead author.

Baseline
Participant flow — Baseline
MilestoneStandard of Care for 24 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 25Standard of Care for 26 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 27Standard of Care for 28 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 29Standard of Care for 30 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 31Standard of Care for 32 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 33Standard of Care for 34 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 35Standard of Care for 36 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 37Standard of Care for 38 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 39Standard of Care for 40 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 41Standard of Care for 42 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 43
Started1062106918931553705128275086910432223
Completed81010091498140856912245546948771650
Not completed2526039514513658196175166573
Week 25-26
Participant flow — Week 25-26
MilestoneStandard of Care for 24 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 25Standard of Care for 26 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 27Standard of Care for 28 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 29Standard of Care for 30 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 31Standard of Care for 32 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 33Standard of Care for 34 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 35Standard of Care for 36 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 37Standard of Care for 38 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 39Standard of Care for 40 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 41Standard of Care for 42 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 43
Started1018317911855100657089193
Completed79821441014599426075151
Not completed221351710123101442
Week 26-27
Participant flow — Week 26-27
MilestoneStandard of Care for 24 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 25Standard of Care for 26 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 27Standard of Care for 28 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 29Standard of Care for 30 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 31Standard of Care for 32 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 33Standard of Care for 34 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 35Standard of Care for 36 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 37Standard of Care for 38 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 39Standard of Care for 40 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 41Standard of Care for 42 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 43
Started1089617715577101568794187
Completed72911361356695356774134
Not completed365412011621202053
Week 28-29
Participant flow — Week 28-29
MilestoneStandard of Care for 24 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 25Standard of Care for 26 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 27Standard of Care for 28 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 29Standard of Care for 30 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 31Standard of Care for 32 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 33Standard of Care for 34 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 35Standard of Care for 36 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 37Standard of Care for 38 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 39Standard of Care for 40 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 41Standard of Care for 42 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 43
Started128891811306395798596179
Completed95821461195091547081126
Not completed337351113425151553
Week 30-31
Participant flow — Week 30-31
MilestoneStandard of Care for 24 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 25Standard of Care for 26 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 27Standard of Care for 28 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 29Standard of Care for 30 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 31Standard of Care for 32 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 33Standard of Care for 34 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 35Standard of Care for 36 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 37Standard of Care for 38 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 39Standard of Care for 40 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 41Standard of Care for 42 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 43
Started98741471476695637777191
Completed73701181365494516570149
Not completed25429111211212742
Week 32-33
Participant flow — Week 32-33
MilestoneStandard of Care for 24 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 25Standard of Care for 26 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 27Standard of Care for 28 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 29Standard of Care for 30 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 31Standard of Care for 32 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 33Standard of Care for 34 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 35Standard of Care for 36 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 37Standard of Care for 38 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 39Standard of Care for 40 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 41Standard of Care for 42 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 43
Started1147816814959102738592160
Completed827413313449100577079118
Not completed324351510216151342
Week 34-35
Participant flow — Week 34-35
MilestoneStandard of Care for 24 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 25Standard of Care for 26 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 27Standard of Care for 28 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 29Standard of Care for 30 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 31Standard of Care for 32 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 33Standard of Care for 34 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 35Standard of Care for 36 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 37Standard of Care for 38 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 39Standard of Care for 40 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 41Standard of Care for 42 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 43
Started1168015014267108557499202
Completed917612813256104475983142
Not completed25422101148151660
Week 36-37
Participant flow — Week 36-37
MilestoneStandard of Care for 24 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 25Standard of Care for 26 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 27Standard of Care for 28 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 29Standard of Care for 30 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 31Standard of Care for 32 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 33Standard of Care for 34 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 35Standard of Care for 36 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 37Standard of Care for 38 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 39Standard of Care for 40 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 41Standard of Care for 42 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 43
Started898515014267108727982178
Completed618012813256104526667121
Not completed285221011420131557
Weeks 38-39
Participant flow — Weeks 38-39
MilestoneStandard of Care for 24 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 25Standard of Care for 26 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 27Standard of Care for 28 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 29Standard of Care for 30 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 31Standard of Care for 32 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 33Standard of Care for 34 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 35Standard of Care for 36 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 37Standard of Care for 38 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 39Standard of Care for 40 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 41Standard of Care for 42 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 43
Started917917113772101766995224
Completed64761301226198614779162
Not completed273411511315221662
Weeks 40-41
Participant flow — Weeks 40-41
MilestoneStandard of Care for 24 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 25Standard of Care for 26 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 27Standard of Care for 28 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 29Standard of Care for 30 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 31Standard of Care for 32 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 33Standard of Care for 34 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 35Standard of Care for 36 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 37Standard of Care for 38 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 39Standard of Care for 40 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 41Standard of Care for 42 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 43
Started111951951596390747186193
Completed346421117222191553
Not completed77891531484688525271140
Weeks 42-43
Participant flow — Weeks 42-43
MilestoneStandard of Care for 24 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 25Standard of Care for 26 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 27Standard of Care for 28 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 29Standard of Care for 30 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 31Standard of Care for 32 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 33Standard of Care for 34 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 35Standard of Care for 36 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 37Standard of Care for 38 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 39Standard of Care for 40 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 41Standard of Care for 42 Weeks, Then Prospective Audit-and-feedback at Discharge Starting at Week 43
Started422357549566251419263304278795
Completed299344446518196405200242229573
Not completed12313103485514636249222

Outcome measures

PrimaryNumber of Patients With Post-discharge Antibiotic Exposure

Post-discharge antibiotic exposure captures the number of hospitalized patient who were discharged with an antibiotic to take after discharge.

Time frame:
Antibiotics prescribed at the time of hospital discharge for the patient to take after discharge
Reported as:
Count of participants · Participants
Number of Patients With Post-discharge Antibiotic Exposure
ParticipantsProspective Audit-and-feedback at DischargeStandard of Care
Number of Patients With Post-discharge Antibiotic Exposure1645 ± 5.63133 ± 5.2
Statistical analysis
  • Prospective Audit-and-feedback at Discharge vs Standard of Care · Odds ratio (or): 0.94 · 95% CI 0.84 to 1.05
SecondaryInpatient Antibiotic Length of Therapy

Inpatient antibiotic LOT will be calculated by measuring inpatient LOT across all patients exposed to inpatient antibiotics on the participating services during the study period.

Time frame:
Every two-week period through study completion (48 weeks total)
Reported as:
Mean · Length of antibiotic therapy in days
Inpatient Antibiotic Length of Therapy
Length of antibiotic therapy in daysProspective Audit-and-feedback at DischargeStandard of Care
Inpatient Antibiotic Length of Therapy4.2 ± 3.54.4 ± 3.6
Statistical analysis
  • Prospective Audit-and-feedback at Discharge vs Standard of Care · Mean difference (net): 0.04 · 95% CI -0.20 to 0.27
SecondaryPercentage of Participants With Hospital Readmission

Hospital readmissions reflect the need for (re) admission to an acute-care bed at a participating facility for any indication within 30 days of the patient's discharge.

Time frame:
30 days from discharge
Reported as:
Count of participants · Participants
Percentage of Participants With Hospital Readmission
ParticipantsProspective Audit-and-feedback at DischargeStandard of Care
Percentage of Participants With Hospital Readmission9691786
Statistical analysis
  • Prospective Audit-and-feedback at Discharge vs Standard of Care · Odds ratio (or): 1.02 · 95% CI 0.88 to 1.18
PrimaryLength of Post-discharge Antibiotic Therapy

Duration in days of the post-discharge antibiotics that were prescribed

Time frame:
Antibiotics prescribed at the point of hospital discharge
Reported as:
Mean · Days
Length of Post-discharge Antibiotic Therapy
DaysProspective Audit-and-feedback at DischargeStandard of Care
Length of Post-discharge Antibiotic Therapy7.6 ± 5.67.1 ± 5.2
Statistical analysis
  • Prospective Audit-and-feedback at Discharge vs Standard of Care · Mean difference (net): 0.02 · 95% CI -0.50 to 0.53

Adverse events

Collected over From the point of hospital discharge through 30 days after hospital discharge, up to 30 days. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Prospective Audit-and-feedback at Discharge242/7,554 (3.2%)969/7,554 (12.8%)379/7,554 (5%)
Standard of Care527/14,288 (3.7%)1,786/14,288 (12.5%)740/14,288 (5.2%)
Most frequent serious events
Most frequent serious events
EventProspective Audit-and-feedback at DischargeStandard of Care
Hospital readmissionGeneral disorders969/75541786/14288
Most frequent other events
Most frequent other events
EventProspective Audit-and-feedback at DischargeStandard of Care
Fluoroquinolone use at hospital dischargeProduct Issues379/7554740/14288

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Prospective Audit-and-feedback at DischargeStandard of CareTotal
Median65 (53 to 75)66 (53 to 75)66 (53 to 75)
Sex: Female, Male
Sex: Female, Male(Participants)Prospective Audit-and-feedback at DischargeStandard of CareTotal
Female302354398462
Male4531884913380
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Prospective Audit-and-feedback at DischargeStandard of CareTotal
American Indian or Alaska Native214768
Asian73119192
Native Hawaiian or Other Pacific Islander346397
Black or African American215439576111
White5123976714890
More than one race31013
Unknown or Not Reported146325471
Primary hospital service was a Medicine team
Primary hospital service was a Medicine team(Participants)Prospective Audit-and-feedback at DischargeStandard of CareTotal
Count of participants73291392821257
08

Study locations

5 sites
  • Richard Roudebush VA Medical Center
    Indianapolis, Indiana 46202, United States
  • University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242, United States
  • Baltimore VA Medical Center
    Baltimore, Maryland 21201-1524, United States
  • Barnes Jewish Hospital and affiliated hospitals
    St Louis, Missouri 63110, United States
  • Audie L Murphy VA Medical Center
    San Antonio, Texas 78229, United States
09

References and documents

Publications

  • Livorsi DJ, Thompson AM, Green MS, Hoelscher AC, Chu KK, Neuner E, Burnett Y, Hopkins T, Walter E, Dave R, Tripathi R, Lohmar H, Dysangco A, Percival K, Ince D, Kolkmeyer J, Newland H, Hendrix MJ, Clore G, Poe C, O'Shea A, Tholany J, Prasidthrathsint K, Rachmiel E, Bongu J, Bewley A, Hsueh K. Prospective Audit and Feedback by Antibiotic Stewardship Teams to Reduce Antibiotic Overuse at Hospital Discharge: A Stepped-Wedge Cluster-Randomized Clinical Trial. JAMA Netw Open. 2026 Jan 2;9(1):e2549655. doi: 10.1001/jamanetworkopen.2025.49655. PubMed 41511774 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — All data will be aggregated to the hospital-level without including patient identifiers. This is a requirement for transmitting data across the institutions participating in this trial.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2022 to primary completion in Nov 2023, 11 months.

Results were first posted in Nov 2026, 2 years 11 months after primary completion.

Of 276 non-industry interventional studies with no phase under Infections, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 51. This study's 11 months is below that.

Counting every sponsor, half of 308 studies reached it within 24 months; a quarter within 9 and three quarters within 48.

Infections covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

Start moved once since we started tracking on Sep 25, 2026: May 2023 → Dec 2022, on Nov 9, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 13, 2022
First posted
Jul 25, 2022
StartActual
Dec 5, 2022was May 2023
Primary completionActual
Nov 19, 2023
CompletionActual
Sep 9, 2024
Results first posted
Nov 9, 2026
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Nov 9, 2026
Sites
1 site added, 1 site removed
Show site
  • Barnes Jewish Hospital and affiliated hospitals · St Louis, United States
Show 1 removed
  • Barnes Jewish Hospital and affiliated hospitals · Saint Louis, United States
Nov 9, 2026
Start date
May 22, 2023→Dec 5, 2022
Nov 9, 2026
Enrollment
10→21842
Nov 9, 2026
Primary outcomes
1 edited, 1 added
What changed in the outcomes
  • EditedNumber of Patients With Post-discharge antibiotic length of therapyAntibiotic ExposureTime frame: Every 2-week-period through study completion (48 weeks total) → Antibiotics prescribed at the time of hospital discharge for the patient to take after discharge
  • AddedLength of Post-discharge Antibiotic TherapyTime frame: Antibiotics prescribed at the point of hospital discharge
Nov 9, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 41511774 ↗
Nov 9, 2026
Secondary outcomes
2 edited
What changed in the outcomes
  • EditedInpatient antibiotic lengthAntibiotic Length of therapyTherapyTime frame: Every two-week period through study completion (48 weeks total)
  • EditedPercentage of participants with hospital readmissionParticipants With Hospital ReadmissionTime frame: 30 days from discharge
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Results posted
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 41511774 ↗
    1 site added, 1 site removed
    Show site
    • Barnes Jewish Hospital and affiliated hospitals · St Louis, United States
    Show 1 removed
    • Barnes Jewish Hospital and affiliated hospitals · Saint Louis, United States
    Start date May 22, 2023→Dec 5, 2022
    Enrollment 10→21842
    Primary outcomes 1 edited, 1 added
    What changed in the outcomes
    • EditedNumber of Patients With Post-discharge antibiotic length of therapyAntibiotic ExposureTime frame: Every 2-week-period through study completion (48 weeks total) → Antibiotics prescribed at the time of hospital discharge for the patient to take after discharge
    • AddedLength of Post-discharge Antibiotic TherapyTime frame: Antibiotics prescribed at the point of hospital discharge
    Secondary outcomes 2 edited
    What changed in the outcomes
    • EditedInpatient antibiotic lengthAntibiotic Length of therapyTherapyTime frame: Every two-week period through study completion (48 weeks total)
    • EditedPercentage of participants with hospital readmissionParticipants With Hospital ReadmissionTime frame: 30 days from discharge
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT05471726
Lead sponsor
Iowa City Veterans Affairs Medical Center
Responsible party
Sponsor
First posted
Jul 25, 2022
Start date
Dec 5, 2022
Primary completion
Nov 19, 2023
Completion
Sep 9, 2024
Results posted
Nov 9, 2026
Last update
Nov 9, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion